Week in Review: November 30–December 4

Historic meeting on human gene editing; signs of obesity found in sperm epigenome; top 10 innovations of 2015; dealing with retractions

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Hundreds of scientists, bioethicists, and historians gathered in Washington, DC, this week for a discussion on human gene editing at a summit organized by two US National Academies, the Chinese Academy of Sciences, and the U.K.’s Royal Society. For three days, the biggest names in genome editing, including the three discoverers of CRISPR itself (Jennifer Doudna, Emmanuelle Charpentier, and Feng Zhang), talked about what’s possible with new precision gene editors, where the challenges still lie, and the best way to move the technology forward. “We could be on the cusp of a new era in human history,” Cal Tech’s David Baltimore, chair of the Summit Planning Committee, said in his opening remarks Tuesday (December 1). “Although gene editing is in its infancy today, it is likely that the pressure to use gene editing will increase in time, and the actions we take now will guide us into the future.”

FLICKR, ZAPPYS TECHNOLOGY SOLUTIONSAdding to a growing body of evidence that a father’s environment and experience can affect his offspring, researchers this week (December 3) found differences in the epigenomes of lean and obese men’s sperm, as well as in the epigenomes of sperm from obese men before and after bariatric surgery, according to a study published in Cell Metabolism. “Obese men have information that can be transferred to children that could potentially affect their eating behavior. And this information can be changed if obese men lose weight,” said study coauthor Romain Barrès from the University of Copenhagen. “Our study doesn’t show what is transmitted to children, but it is likely that something is transmitted, and it will change brain development and behavior.”

The study is a “provocative start to asking some really interesting questions,” said Tracy Bale, a neuroscientist at the University of Pennsylvania who was not involved in the work. “The big picture here is fascinating. It does support the very important potential role of the environment to influence epigenetic marks in dads’ germ cells.”

The Scientist released its list of the hottest innovations in life science this year, selected by an independent panel of judges based on their potential impacts on science and medicine. This year’s winners include sequencing advances, a new take on an old light microscope, and, of course, CRISPR genome editing.

© DUSAN PETRICICThis month’s issue of The Scientist takes a look at the growing number of retractions in life-science research. Attorney John Thomas, who represents scientific whistleblowers in a variety of matters, writes about how to recognize red flags of potential wrongdoing in your lab, while Associate Editor Kerry Grens talks with researchers who’ve had to deal with retractions firsthand about the best way to approach the problem. Hervé Maisonneuve of the University of Paris-Sud and Evelyne Decullier of the Hospices Civils de Lyon in France recommend using a standardized form when publishing retraction notices, to help readers discern whether the data, or just the conclusions drawn from them, are flawed.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies